Rise Advisors’s ResMed RMD Stock Holding History

Rise Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-100	Closed	-$27.3K	–	1152
2025 Q3	$27.3K	Buy	100 +5	+5%	+$1.37K	0.01%	421
2025 Q2	$24.6K	Hold	95	–	–	0.01%	422
2025 Q1	$21.3K	Sell	95 -8	-8%	-$1.87K	0.01%	465
2024 Q4	$23.5K	Hold	103	–	–	0.01%	546
2024 Q3	$25.1K	Hold	103	–	–	0.01%	525
2024 Q2	$19.6K	Sell	103 -15	-13%	-$3.04K	0.01%	649
2024 Q1	$23.3K	Buy	118 +103	+687%	+$18.9K	0.01%	543
2023 Q4	$2.64K	Hold	15	–	–	﹤0.01%	435
2023 Q3	$2.26K	Hold	15	–	–	﹤0.01%	452
2023 Q2	$3.33K	Hold	15	–	–	﹤0.01%	455
2023 Q1	$3.33K	Hold	15	–	–	﹤0.01%	506
2022 Q4	$3.16K	Hold	15	–	–	﹤0.01%	502
2022 Q3	$3K	Hold	15	–	–	﹤0.01%	508
2022 Q2	$3K	Hold	15	–	–	﹤0.01%	512
2022 Q1	$5K	Hold	15	–	–	﹤0.01%	431
2021 Q4	$3.93K	Buy	+15	New	+$3.89K	﹤0.01%	441

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Rise Advisors's RMD Position: Q4 2025 in Review

Rise Advisors sold out of ResMed (RMD) in Q4 2025, closing a stake of 100 shares — an estimated $27.3K sold.

Rise Advisors first reported a position in RMD in Q4 2021 and held it in 16 quarters. The position peaked at $27.3K in Q3 2025. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

Rise Advisors reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
Rise Advisors sold 100 ResMed shares in Q4 2025, an estimated $27.3K.
Rise Advisors first reported a position in ResMed in Q4 2021 and held it in 16 quarters.
Rise Advisors's ResMed position peaked at $27.3K in Q3 2025.
948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.